23 July 2024 - Telix today announces that the US FDA has accepted the filing of its new drug application for ...
24 July 2024 - According to a recent study, medicines are approved on average 249 days later in Switzerland than by ...
15 July 2024 - Talk of the delay in drugs is top of mind for Ford, who arrived in Nova Scotia ...
11 July 2024 - Project Orbis is a global initiative that aims to streamline regulatory review processes across international regulators in ...
10 July 2024 - The Health Technology Assessment (HTA) Policy and Methods Review concluded on 4 May 2024. The HTA ...
24 June 2024 - Committed to a process of continuous development of its methods, the High Authority of Health is launching ...
1 July 2024 - The FDA’s breakthrough therapy designation program was created to increase patient access to safe and effective therapies ...
12 June 2024 - Each year, the European Pharmaceutical Industry Association (EFPIA) publishes data comparing the availability of new medicines across ...
31 May 2024 - Oral sulopenem NDA has been assigned a PDUFA action date of 25 October 2024. ...
31 May 2024 - Regeneron Pharmaceuticals and Sanofi today announced the US FDA has extended by three months the target action ...
29 May 2024 - Scientific analysis confirms successful Swissmedic participation in international initiative to expedite access to innovative cancer drugs. ...
23 May 2024 - NHS patients in England will benefit from faster access to the most innovative and cutting-edge medical technologies ...
21 May 2024 - Updated PDUFA goal date of 29 December 2024. ...
14 May 2024 - PDUFA goal date extended by three months for further review of submission to 14 August 2024. ...
13 May 2024 - Expedited market access for novel and efficacious drugs is warranted for patients. Since 2020, Swissmedic (The Swiss ...